
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – M
MYND Diagnostics was formed to commercialize proprietary biomarker diagnostic tests for patients suffering from MDD, TRD and other...
MYND Life Sciences Announces Diagnostic Division with Formation of Wholly-Owned Subsidiary – M
MYND Life Sciences Inc. Announces RSU Grant
MYND Life Sciences Announces Closing of Fully Subscribed $3 Million Convertible Debenture Unit Offer